Skip to main content
Fig. 5 | Trials

Fig. 5

From: Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials

Fig. 5

Ranked perceptions of the private sector organisations on important barriers to adaptive designs (ADs) use in confirmatory trials. Red diamonds indicate barriers that were ranked higher by the private sector than UK Clinical Trials Units (CTUs). Blue squares indicate barriers that were ranked higher by the UK CTUs than the private sector

Back to article page